Mechanistic aspects of C-H activation by Pt complexes.

Chem Rev

Department of Chemistry, University of Oslo, Norway.

Published: June 2005

Download full-text PDF

Source
http://dx.doi.org/10.1021/cr030710yDOI Listing

Publication Analysis

Top Keywords

mechanistic aspects
4
aspects c-h
4
c-h activation
4
activation complexes
4
mechanistic
1
c-h
1
activation
1
complexes
1

Similar Publications

Mechanistic Insight of Pharmacological Aspects of Violacein: Recent Trends and Advancements.

J Biochem Mol Toxicol

February 2025

Research and Scientific Studies Unit, College of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.

Since its discovery in the bacterium Chromobacterium violaceum, violacein-a striking purple pigment-has garnered significant interest due to its promising applications in the food and pharmaceutical industries. Violacein exhibits a range of pharmacological properties, including anti-inflammatory, anticancer, antibacterial, and antiparasitic effects, yet its complete molecular mechanisms are still being elucidated. Its mechanisms of action likely involve complex interactions with cellular receptors, signaling pathways, and specific molecular targets.

View Article and Find Full Text PDF

Atrial fibrillation (AF), impacting nearly 50 million individuals globally, is a major contributor to ischaemic strokes, predominantly originating from the left atrial appendage (LAA). Current clinical scores like CHA₂DS₂-VASc, while useful, provide limited insight into the pro-thrombotic mechanisms of Virchow's triad-blood stasis, endothelial damage, and hypercoagulability. This study leverages biophysical computational modelling to deepen our understanding of thrombogenesis in AF patients.

View Article and Find Full Text PDF

Decoding the SARS-CoV-2 infection process: Insights into origin, spread, and therapeutic approaches.

Microb Pathog

January 2025

Department of Bioengineering, Faculty of Engineering, Integral University, Lucknow, 226026, India. Electronic address:

Globally, over 768 million confirmed cases and 6.9 million deaths had been documented as of July 17, 2023. Coronaviruses have a relatively large RNA genome.

View Article and Find Full Text PDF

Animal models of kabuki syndrome and their applicability to novel drug discovery.

Expert Opin Drug Discov

January 2025

Division of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

Introduction: Kabuki Syndrome (KS) is a rare genetic disorder characterized by distinctive facial features, intellectual disability, and multiple congenital anomalies. It is caused by pathogenic variants in the and genes. Despite its significant disease burden, there are currently no approved therapies for KS, highlighting the need for advanced research and therapeutic development.

View Article and Find Full Text PDF

Background/objectives: Colorectal cancer (CRC) holds the third and second position among cancers affecting men and women, respectively. Frequently, the first-line treatment for metastatic CRC consists of the intravenous administration of 5-fluorouracil and leucovorin in combination with oxaliplatin or irinotecan. Physiologically-based pharmacokinetic models (PBPK) aim to mechanistically incorporate body physiology and drug physicochemical attributes, enabling the description of both systemic and organ drug exposure based on the treatment specificities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!